You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Skin conditions
  5. Psoriasis

Ustekinumab for the treatment of adults with moderate to severe psoriasis

  • Technology appraisal guidance
  • Reference number: TA180
  • Published:  23 September 2009
  • Last updated:  03 March 2017
  • Guidance
  • Tools and resources
  • Information for the public
  • History

Information for the public

  • Ustekinumab for the treatment of adults with moderate to severe psoriasis (PDF 59 KB)

    Published:
    23 September 2009
  • Gwybodaeth i'r cyhoedd (PDF 55 KB)

    Published:
    29 October 2009
Back to top